Substance Abuse

Fidelis Care Behavioral Health Grant Applications Now Open to Providers and Organizations Across New York State

Retrieved on: 
星期三, 五月 1, 2024
Disability, Administration, EDT, Health, Risk, Mental Health Awareness Month, DSM-IV codes, Inequality, Mental disorder, National Alliance, Violence, Substance Abuse, Poverty, Centene Corporation, World Health Organization, Mental health service, Fidelis Care, Nursing

LONG ISLAND CITY, N.Y., May 1, 2024 /PRNewswire/ -- In observance of Mental Health Awareness Month, Fidelis Care, a statewide health plan with more than 2.4 million members in New York State and a wholly owned subsidiary of Centene Corporation, has opened the application process for its 2024 behavioral health grant program. The grants range from $10,000 to $20,000 each and are aimed at assisting providers and community-based organizations that support behavioral health and wellness, especially in underserved communities. The application is available at fideliscare.org/BH-grants. Deadline to apply is 5 p.m. EDT May 31, 2024.  

Key Points: 
  • The grants range from $10,000 to $20,000 each and are aimed at assisting providers and community-based organizations that support behavioral health and wellness, especially in underserved communities.
  • "Recognizing and addressing disparities is critical in ensuring that everyone has equal access to behavioral health support and resources," said Fidelis Care Chief Medical Officer Dr. Vincent Marchello.
  • "These grants can help deepen Fidelis Care's relationships with providers and community-based social need service organizations to get people the help they need to live fulfilling lives."
  • Fidelis Care plans to announce the recipients of its 2024 behavioral health grant program awards by July 31, 2024.

Pelago Introduces Cannabis Use Disorder Treatment Program

Retrieved on: 
星期二, 四月 23, 2024
Cannabis, Mental Health, Health, Telemedicine, Virtual Medicine, Natural Resources, Managed Care, General Health, SAMHSA, Recreation, Risk, Suds, Tobacco, Research, Depression, Substance Abuse, Clinical, Drug, Cognitive behavioral therapy, Workforce, CUD, Multimedia, CBT, Anxiety, Series, Knowledge, Overalls, Ageing

View the full release here: https://www.businesswire.com/news/home/20240423342287/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20240423342287/en/
    Pelago digital cannabis use treatment program (Photo: Business Wire)
    “We’re at an important inflection point in the U.S., with cannabis use disorders on the rise as treatment simultaneously declines,” said Pelago CEO and Co-Founder Yusuf Sherwani, M.D.
  • Immediately following the Series C fundraise, Pelago launched its contingency management program and is now adding cannabis use disorder (CUD) treatment to help employers and health plans address rising rates and costs of substance use.
  • Pelago’s cannabis program is leveraging the first two approaches at launch, along with other key program elements, including physician-led care, personalized CBT, and complex condition management, and will evolve its contingency management program to include cannabis later in 2024.
  • For more information about Pelago's cannabis use disorder treatment program and its existing suite of substance use management solutions, visit www.pelagohealth.com or contact a member of our team .

QuidelOrtho Adds Fentanyl Test to Its Vitros® Systems as a MicroTip® Partnership Assay

Retrieved on: 
星期三, 四月 10, 2024
Science, Biotechnology, Research, Pharmaceutical, Medical Supplies, Health, Medical Devices, Hospitals, Urine, Addiction, Mortality, University, Fentanyl, Risk, Hospital, CDC, 7600, UMD, XT, Substance Abuse, Fatality, Medicine, Multimedia, Maryland School, Assistant, QuidelOrtho, Pharmaceutical industry

QuidelOrtho Corporation (Nasdaq: QDEL) has added the ARK™ Fentanyl II Assay to its U.S. Vitros® XT 7600 and 5600 Integrated Systems as well as its Vitros® 4600 Chemistry System menu of assays as a MicroTip® Partnership Assay (“MPA”).

Key Points: 
  • QuidelOrtho Corporation (Nasdaq: QDEL) has added the ARK™ Fentanyl II Assay to its U.S. Vitros® XT 7600 and 5600 Integrated Systems as well as its Vitros® 4600 Chemistry System menu of assays as a MicroTip® Partnership Assay (“MPA”).
  • This Fentanyl assay will help hospital and emergency room customers respond to the critical demand for enhanced opioid testing, allowing on-site fentanyl testing in less than 10 minutes to aid in immediate clinical decisions.
  • As part of QuidelOrtho’s Vitros systems’ menu of assays, the test offers clinical fentanyl testing for hospitals and emergency departments, providing an effective approach to preliminary urine drug testing.
  • When patients test positive for opioids on a standard drug test, they’re usually directed to drug treatment programs.

Pelago Announces Launch of Contingency Management Program

Retrieved on: 
星期二, 四月 9, 2024
Mental Health, Health, Technology, Health Technology, Other Health, General Health, Reward, ROI, Motivation, SAMHSA, Suds, Tobacco, Systematic review, Glasner, Multimedia, Substance Abuse, Economics, Meta-analysis

Pelago , the leading digital clinic partner to U.S. businesses and health plans for substance use management, has introduced contingency management to reward behaviors most likely to improve member engagement, motivation and health outcomes.

Key Points: 
  • Pelago , the leading digital clinic partner to U.S. businesses and health plans for substance use management, has introduced contingency management to reward behaviors most likely to improve member engagement, motivation and health outcomes.
  • With the introduction of this evidence-based treatment program, Pelago becomes the first nationwide digital substance use management provider to offer contingency management (CM), which will be incorporated into its comprehensive substance use disorder (SUDs) treatment offerings.
  • An earlier meta-analysis found that contingency management resulted in successful treatment episodes 61% of the time compared to 39% for other modalities.
  • For more information on how our contingency management program could benefit your population, visit www.pelagohealth.com Or contact a member of our team .

YesCare has Joined Leading Multiagency Initiative on Opioid Use

Retrieved on: 
星期二, 四月 2, 2024
Public Policy, Government, Law Enforcement, Emergency Services, Mental Health, State, Local, Health, Managed Care, General Health, Mental health, Policy, SAMHSA, Partnership, ADOC, Prison, MAT, Public, Patient, Recidivism, Psychological abuse, Opioid use disorder, Federal Prison Camp, Pensacola, Senior counsel, Lean Six Sigma, Opioid, Substance Abuse, Nursing

This multiagency initiative focused on Medication Assisted Treatment (MAT) in prisons will be a collaboration led by SAMHSA (the federal agency charged with advancing behavioral health since 1992) along with YesCare, ADOC, the Alabama Department of Mental Health, the Alabama Board of Pardons and Parole, and the State Opioid Treatment Authority.

Key Points: 
  • This multiagency initiative focused on Medication Assisted Treatment (MAT) in prisons will be a collaboration led by SAMHSA (the federal agency charged with advancing behavioral health since 1992) along with YesCare, ADOC, the Alabama Department of Mental Health, the Alabama Board of Pardons and Parole, and the State Opioid Treatment Authority.
  • The Policy Academy is a part of the Biden-Harris Administration's efforts to address the opioid overdose epidemic and to support recovery among Americans experiencing substance use disorders.
  • “Through this partnership, Alabama will be on the leading edge of MAT implementation, and success here will allow for an optimized roll out of improved programs nationwide,” said Jeff Sholey, CEO of YesCare.
  • “To be selected by SAMHSA for this initiative reflects a true testament to the partnership we share with ADOC, and the common dedication we have in helping those with Opioid Use Disorders.

PRESIDENT BIDEN REAFFIRMS COMMITMENT TO MENTAL HEALTH AND SUICIDE PREVENTION IN FISCAL YEAR 2025 BUDGET PROPOSAL

Retrieved on: 
星期二, 三月 12, 2024
Community, BIPOC, Depression, Mental health, Congress, AFSP, SAMHSA, Mental, COVID-19, Education, Ageing, Loneliness, Research, Suicide, Hope, Death, Grammatical mood, Suicidal ideation, Annual report, CDC, CSP, Multimedia, Administration, Substance Abuse, Pharmaceutical industry

NEW YORK, March 12, 2024 /PRNewswire/ -- The American Foundation for Suicide Prevention (AFSP), the nation's largest suicide prevention organization, today applauds President Biden and his recently released 2025 budget proposal giving significant funding and attention to critical suicide prevention and mental health activities in the upcoming fiscal year beginning October 1.

Key Points: 
  • NEW YORK, March 12, 2024 /PRNewswire/ -- The American Foundation for Suicide Prevention (AFSP), the nation's largest suicide prevention organization, today applauds President Biden and his recently released 2025 budget proposal giving significant funding and attention to critical suicide prevention and mental health activities in the upcoming fiscal year beginning October 1.
  • $68 million for the Centers for Disease Control and Prevention's Comprehensive Suicide Prevention Program (CSP), an increase of $38 million over FY 23.
  • $1.043 billion for the Community Mental Health Services Block Grant program, an increase of $35 million over FY 23.
  • We are also pleased that the budget expands CDC's Comprehensive Suicide Prevention Program, which will bring community-based public health approaches to preventing suicide to additional locations across the country.

Netsmart Supports Whole-Person Care Provisions in 42 CFR Part 2 Final Rule

Retrieved on: 
星期二, 二月 20, 2024
Software, Practice Management, Telemedicine, Virtual Medicine, Managed Care, Health, Mental Health, Health Technology, Technology, Diabetes, SAMHSA, Senior, Roger Hawkins (drummer), Person, Record, Confidentiality, Part, Coronavirus, Substance Abuse, Partnership, Mental, CFR, Substance use disorder, Economy, HHS, HITECH, HIPAA, History, Health information technology, Part Two, OCR, Patient, Economic security, Privacy, Civil and political rights, DSM-IV codes, Accountability Act, Cancer, Medical device

Strengthens penalties by applying the same requirements of the HIPAA Breach Notification Rule to breaches of records under Part 2.

Key Points: 
  • Strengthens penalties by applying the same requirements of the HIPAA Breach Notification Rule to breaches of records under Part 2.
  • As a founding member of The Partnership to Amend 42 CFR Part 2 , Scalia stated the long-awaited Final Rule is another step forward for coordinated, whole-person care for individuals nationwide.
  • These major changes to 42 CFR Part 2 will take effect on February 16, 2026.
  • To learn more about these regulation changes, read the 42 CFR Part 2 Final Rule Fact Sheet and register for the upcoming Netsmart webinar on Thursday, March 28 at 1 p.m.

First-of-its-Kind Study Reveals Potential Impact of Behavioral Health Crisis Systems on Reducing Costly, Avoidable Hospital Events

Retrieved on: 
星期三, 二月 28, 2024
SAMHSA, Research, Bed, Substance Abuse, Psychiatric Services, Hospital, Health information management, University, Suicide, Medicaid, AHCCCS, Psychiatry

PHOENIX, Feb. 28, 2024 /PRNewswire/ -- Access to a comprehensive behavioral health crisis response system can lessen demand for more restrictive and costly emergency department and inpatient services, according to a new research study published in the journal Psychiatric Services. The study was conducted by a team that included researchers from Arizona State University Center for Health Information and Research and Connections Health Solutions.

Key Points: 
  • The study was conducted by a team that included researchers from Arizona State University Center for Health Information and Research and Connections Health Solutions .
  • The analysis revealed:
    The majority of individuals (57.4%) entered the crisis system through mobile crisis or crisis facilities versus the emergency department, indicating the crucial role these services play in crisis response.
  • Of individuals who did reutilize services, the majority (73.0%) utilized mobile or facility-based crisis services rather than emergency department or inpatient services, affirming the significance of crisis systems in preventing hospital utilization.
  • "This study shows that crisis systems can serve a large proportion of individuals in crisis, reducing the need for more restrictive and costly levels of care."

Release Foundation Launches Youth and Young Adult Mental Health Fund

Retrieved on: 
星期二, 二月 27, 2024
Mental, SAMHSA, Mental health, Substance Abuse, Young adult, Nursing

NEW YORK, Feb. 27, 2024 /PRNewswire/ --  Release Foundation, which provides scholarships for substance use disorder and mental health treatment to those who need it but otherwise can't afford it, is proud to announce the launch of its Youth and Young Adult Mental Health Fund amid the nation's youth mental health crisis. The fund's goal is to make evidence-based mental health treatment accessible to adolescents and young adults ages 11 to 35, regardless of socioeconomic status.

Key Points: 
  • NEW YORK, Feb. 27, 2024 /PRNewswire/ -- Release Foundation , which provides scholarships for substance use disorder and mental health treatment to those who need it but otherwise can't afford it, is proud to announce the launch of its Youth and Young Adult Mental Health Fund amid the nation's youth mental health crisis.
  • In support of Release Foundation's new initiative, Charlie Health will offer its clinical expertise and resources to scholarship recipients of the Youth and Young Adult Mental Health Fund.
  • Young people and their families will have access to dozens of weekly support groups facilitated by Charlie Health professionals specializing in mental health and fostering connections.
  • "With the Youth and Young Adult Mental Health Fund and clinical support from a top-tier provider like Charlie Health, I'm excited about the impact we can make on such a critical population."

SAMHSA Awards ICF New Work Totaling $24 Million

Retrieved on: 
星期三, 二月 7, 2024
Cloud, Partnership, ICF, Substance Abuse, Leverage, Machine learning, Ecosystem, Artificial intelligence, Data, SAMHSA, Amazon Web Services, Employment, Mental health, ICFI, Lifeline, Health, AWS, Legal drinking age, Nursing

RESTON, Va., Feb. 7, 2024 /PRNewswire/ -- The Substance Abuse and Mental Health Administration (SAMHSA) expanded its longstanding partnership with ICF, a global consulting and technology services provider (NASDAQ:ICFI), with five new subcontracts to support mental health programs, including evaluation and communications support for the agency's 988 Suicide & Crisis Lifeline. The agreements have a combined value of $24 million.

Key Points: 
  • "These new agreements expand our longstanding partnership with SAMHSA to help the agency better evaluate the impact of and raise awareness for mental health programs that change and save lives.
  • We are proud to be a trusted partner to SAMHSA in helping advance their critical public health mission."
  • For three of the five service agreements, ICF will deliver a variety of behavioral health and technology-based support services, totaling $16.1 million.
  • For two of the five service agreements, ICF will support SAMHSA's substance misuse and mental health programs, totaling $8 million.